DR. AMIEL YEHUDA TOKAYER M.D. NPI 1346240694

NPI Information

  • NPI: 1346240694
  • Provider Name: DR. AMIEL YEHUDA TOKAYER, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 6056 BOYNTON BEACH BLVD STE 145
    BOYNTON BEACH, FL
    ZIP 33437
  • Phone: (561) 439-1800

Map and Directions

Get Directions

NPI Details

DR. Amiel Yehuda Tokayer, M.D. is a rheumatology internal medicine in Boynton Beach, FL with 30 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Amiel Yehuda Tokayer, M.D. NPI is 1346240694. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Graduation Year:1995

The provider's business location address is:

6056 BOYNTON BEACH BLVD STE 145
BOYNTON BEACH, FL
ZIP 33437-500
Phone: (561) 439-1800
Fax: (561) 439-4874

The NPI 1346240694 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
  • Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg (HCPCS:J7329)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of trigger points, 1-2 muscles (HCPCS:20552)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection into tendon or ligament (HCPCS:20550)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • X-ray of knee, 3 views (HCPCS:73562)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of trigger points, 3 or more muscles (HCPCS:20553)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of anesthetic agent and/or steroid into lower back and leg nerve (HCPCS:64445)
  • X-ray of upper spine, 4-5 views (HCPCS:72050)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
  • X-ray of hip, 2-3 views (HCPCS:73502)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection into tendon at attachment to bone or muscle (HCPCS:20551)
  • X-ray of middle spine, 2 views (HCPCS:72070)

The enumeration date for this NPI number is 7/28/2005 and was last updated on 1/31/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyME83054FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.